Can a simple drug shield liver transplant patients from dangerous complications?
NCT ID NCT05031026
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 23 times
Summary
This study tests whether giving the drug dexmedetomidine during liver transplant surgery can protect the liver and other organs from damage. The trial involves 60 adults aged 18-60 with a specific liver disease severity score. The goal is to see if the drug reduces complications like early graft failure and kidney injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT; COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Assiut University
Asyut, 088, Egypt
Conditions
Explore the condition pages connected to this study.